Literature DB >> 6952818

N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.

D A Martin, C V Sanders, R L Marier.   

Abstract

The in vitro activity of N-formimidoyl thienamycin (MK0787) was tested against 239 anaerobic bacteria clinical isolates: 70 of Bacteroides fragilis, 18 of B. distasonis, 16 of B. thetaiotaomicron, 10 of B. vulgatus, 24 of Bacteroides spp., 22 of B. melaninogenicus (all three subspecies), 26 of Fusobacterium spp., 10 of Peptococcus spp., 15 of Peptostreptococcus spp., 15 of Clostridium perfringens, and 13 of Clostridium spp. Ninety-five percent of the isolates were inhibited by less than or equal to 0.125 microgram/ml, and all were inhibited by less than or equal to 4 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952818      PMCID: PMC181847          DOI: 10.1128/AAC.21.1.168

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Medium for use in antibiotic susceptibility testing of anaerobic bacteria.

Authors:  T D Wilkins; S Chalgren
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

2.  Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity.

Authors:  S S Weaver; G P Bodey; B M LeBlanc
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

3.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

4.  In vitro activity of thienamycin.

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

5.  Cefamandole therapy in anaerobic infections.

Authors:  R N Greenberg; M C Scalcini; C V Sanders; A C Lewis
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

6.  MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.

Authors:  H Kropp; J G Sundelof; J S Kahan; F M Kahan; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

7.  In vitro activity of N-formimidoyl thienamycin (MK0787).

Authors:  F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.

Authors:  T Kesado; T Hashizume; Y Asahi
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.

Authors:  J E Brown; V E Del Bene; C D Collins
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

  9 in total
  7 in total

1.  In vitro activity of imipenem against anaerobic bacteria.

Authors:  D Megran; C Carlson; A Chow
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 2.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

3.  In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.

Authors:  S D Shafran; J Wong; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 4.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

5.  Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.

Authors:  H Gnarpe; J Belsheim; C Blomqvist; A Lundbäck
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

6.  Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.

Authors:  D L Shungu; E Weinberg; A T Cerami
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.

Authors:  K E Aldridge; C V Sanders; A Janney; S Faro; R L Marier
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.